TD Ameritrade Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-7,410
| Closed | -$474K | – | 53 |
|
2023
Q2 | $474K | Sell |
7,410
-807
| -10% | -$51.6K | 0.01% | 122 |
|
2023
Q1 | $569K | Sell |
8,217
-1,931
| -19% | -$134K | 0.01% | 120 |
|
2022
Q4 | $730K | Sell |
10,148
-2,800
| -22% | -$201K | 0.01% | 119 |
|
2022
Q3 | $920K | Buy |
12,948
+226
| +2% | +$16.1K | 0.01% | 118 |
|
2022
Q2 | $980K | Sell |
12,722
-3,856
| -23% | -$297K | 0.01% | 122 |
|
2022
Q1 | $1.21M | Buy |
16,578
+1,216
| +8% | +$88.8K | 0.01% | 124 |
|
2021
Q4 | $958K | Buy |
15,362
+13,218
| +617% | +$824K | 0.01% | 131 |
|
2021
Q3 | $129K | Sell |
2,144
-9,534
| -82% | -$574K | ﹤0.01% | 238 |
|
2021
Q2 | $780K | Buy |
11,678
+9,967
| +583% | +$666K | 0.01% | 135 |
|
2021
Q1 | $106K | Hold |
1,711
| – | – | ﹤0.01% | 260 |
|
2020
Q4 | $106K | Sell |
1,711
-433
| -20% | -$26.8K | ﹤0.01% | 260 |
|
2020
Q3 | $129K | Buy |
2,144
+220
| +11% | +$13.2K | ﹤0.01% | 238 |
|
2020
Q2 | $113K | Buy |
1,924
+329
| +21% | +$19.3K | ﹤0.01% | 241 |
|
2020
Q1 | $89K | Sell |
1,595
-710
| -31% | -$39.6K | ﹤0.01% | 246 |
|
2019
Q4 | $148K | Buy |
2,305
+74
| +3% | +$4.75K | ﹤0.01% | 216 |
|
2019
Q3 | $113K | Sell |
2,231
-25
| -1% | -$1.27K | ﹤0.01% | 205 |
|
2019
Q2 | $102K | Buy |
2,256
+258
| +13% | +$11.7K | ﹤0.01% | 202 |
|
2019
Q1 | $95K | Sell |
1,998
-1,675
| -46% | -$79.6K | ﹤0.01% | 195 |
|
2018
Q4 | $191K | Buy |
3,673
+1,609
| +78% | +$83.7K | ﹤0.01% | 160 |
|
2018
Q3 | $128K | Buy |
2,064
+1,535
| +290% | +$95.2K | ﹤0.01% | 162 |
|
2018
Q2 | $29K | Buy |
+529
| New | +$29K | ﹤0.01% | 166 |
|